1. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial 
Vinod H. Thourani, MD, Jessica Forcillo, MD, MS, Nirat Beohar, MD, Darshan Doshi, MD, Rupa Parvataneni, MS, Girma M. Ayele, MD, Ajay J. Kirtane, MD, Vasilis Babaliaros, MD, Susheel Kodali, MD, Chandan Devireddy, MD, Wilson Szeto, MD, Howard C. Herrmann, MD, Raj Makkar, MD, Gorav Ailawadi, MD, Scott Lim, MD, Hersh S. Maniar, MD, Alan Zajarias, MD, Rakesh Suri, MD, E. Murat Tuzcu, MD, Samir Kapadia, MD, Lars Svensson, MD, PhD, Jose Condado, MD, Hanna A. Jensen, MD, PhD, Michael J. Mack, MD, Martin B. Leon, MD 
The Annals of Thoracic Surgery 
Volume 102, Issue 4, Pages (October 2016)
DOI: /j.athoracsur
Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
One-year all-cause mortality Placement of Aortic Transcatheter Valves (PARTNER) 1 cohorts A and B: transcatheter aortic valve replacement (TAVR) only. (CI = confidence interval; GFR = glomerular function rate; HR = hazard ratio.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
One-year all-cause mortality Placement of Aortic Transcatheter Valves (PARTNER) 1 cohort A: transcatheter aortic valve replacement (TAVR) only. (CI = confidence interval; GFR = glomerular function rate; HR = hazard ratio.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
One-year all-cause mortality Placement of Aortic Transcatheter Valves (PARTNER) 1 cohort B: transcatheter aortic valve replacement (TAVR) only. (CI = confidence interval; GFR = glomerular function rate; HR = hazard ratio.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions